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T 
he phenomenon of hybrid resistance occurs when ir- 
radiated F1 hybrid mice reject bone marrow cells (BMC) 
donated by either parent (1). Hybrid resistance is of major 
interest in immunology because it violates the classical laws 
for solid tissue transplantation, upon which the MHC was 
defined. (F1 hybrid mice normally accept solid tissue donated 
by either parent.) Recent studies, including those published 
in this issue (2, 3), have yielded significant insight into the 
relationship between NK cells and this perplexing biological 
phenomenon, providing a means to determine the molecular 
basis  for NK cell specificity for their targets. 
Initially described on the basis of an apparently innate ability 
to kill certain tumor cells, termed natural killing, NK cells 
are now also known to be surface immunoglobulin-negative 
lymphocytes that are important in early host defense against 
infections and in regulating the subsequent specific immune 
response to intracellular pathogens by producing cytokines 
(4). NK cells closely resemble T cells with regard to display 
of cell surface molecules, cytolytic mechanisms to kill their 
cellular targets,  and cytokine production profiles.  It is not 
surprising, therefore, that they may share an immediate com- 
mon progenitor (5,  6). 
NK cells clearly must use a mechanism to discriminate be- 
tween cells that they kill and those that they spare,  such as 
normal cells. However, NK cells differ from T cells in target 
recognition mechanisms in two important ways. First, NK 
cells do not express the TCR/CD3 complex (7). Indeed, NK 
cells do not rearrange TCR genes and appear to be normal 
in mice with genetic abnormalities in TCR gene recombina- 
tion, such as scid, and targeted RAG-1 or RAG-2 deficiency 
(8-10). Second, by contrast to MHC class I-restricted T cells, 
NK cells do not require the expression of MHC class I mole- 
cules on targets for natural killing (11). In fact, NK cells kill 
better when their targets do not express MHC class I.  To 
explain this, K~irre postulated the "missing self" hypothesis, 
suggesting that NK cells survey tissues for MHC class I ex- 
pression that is nearly ubiquitously expressed (12). With ab- 
normal expression of MHC class I,  the NK cell is released 
from this inhibitory influence and the target is killed. Cer- 
tainly, there is now ample in vitro and in vivo evidence to 
support the general tenet of the hypothesis that MHC class 
I inhibits target killing.  Although these findings were ini- 
tially controversial because they were difficult to reproduce, 
more recent studies have shown that not all MHC class I 
molecules were capable of conferring resistance to targets. 
Selective resistance has been surprisingly mapped to the pep- 
tide binding domains of MHC class I molecules (13),  sug- 
gesting that NK cells may discriminate between MHC class 
I molecules by recognition of the MHC class I epitopes that 
are also recognized by T  cells, but in a TCR-independent 
manner. 
In hybrid resistance,  NK cells have been identified as the 
host elements that reject parental BMC (1). Hybrid resistance 
can occur in the apparent absence of immunoglobulin and 
T  cells because it occurs in hosts with the scid mutation. 
Although the presumption is that NK cells are directly cyto- 
toxic against BM precursors, the ability of NK cells to pro- 
duce cytokines, such as interferon-3,, TNF-cr  GM-CSF, etc. 
(4), which may influence bone marrow engraftment raises 
the possibility that differential cytokine production may be 
another mechanism. Nevertheless, even this latter possibility 
suggests that NK cells must be specifically triggered (or in- 
hibited,  see below) to manifest hybrid resistance. 
Parental Determinants  Recognized by Host NK Cells.  Re- 
cipient NK cells mediate BMC rejection by recognizing pa- 
rental determinants encoded by genes that have been mapped 
to the MHC (1). Moreover, an H-2  b mouse transgenic for 
H-2D d resembles the (H-2  b  x  H-2d)F1  hybrid with regard 
to hybrid resistance (14). In addition, host NK cells in other- 
wise  syngeneic hosts  reject MHC  class  I-deficient BMC 
derived  from  mice  with  a  targeted  mutation  in  the  ~2- 
microglobulin gene (15,  16).  This rejection is thus highly 
reminiscent of hybrid resistance.  Taken together,  the data 
strongly suggest that NK cells in F1 hybrid animals mediate 
hybrid resistance against parental BMC cells that do not ex- 
press  the full complement of MHC class I molecules that 
would be codominantly expressed on F1 hybrid cells. 
Other considerations, however, have prevented a consensus 
on this interpretation. The Bennett and Kumar group sug- 
gest that NK cells recognize parental determinants termed 
"hematopoietic histocompatibility" (Hh-1) antigens that can 
be distinguished from MHC molecules for several reasons 
(1). Their extensive studies of MHC-congenic mice demon- 
strated that  the specificity of rejection could not be con- 
veniently grouped according to MHC class I haplotypes of 
either the donor or recipient (17). Moreover, there is significant 
overlap between the groups. This analysis, however, has re- 
quired interpretation without knowledge of putative NK cell 
receptors that presumably also affect the specificity. Analyses 
of MHC recombinant congenic mice have also suggested that 
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reside in a region centromeric to H-2D (17). Although the 
Hh-1 gene may modify or regulate the expression of MHC 
dass I molecules, this separation is confined to a small number 
of recombinant congenic mice with cross-over points near 
H-2D. It remains possible that the H-2D genes in these mice 
may be mutated. Nevertheless, the available data appear to 
contain discrepancies concerning the nature of the parental 
determinants for hybrid resistance. 
How can these issues be resolved? In vitro systems resem- 
bling hybrid resistance (18) coupled with analysis of the spec- 
ificity of NK cell clones or subsets have provided significant 
insight into NK cell receptors. In humans, several groups have 
made extraordinary progress indicating that NK cell clones 
are specifically inhibited by certain MHC class I molecules, 
depending on expression of putative MHC class I-specific 
NK cell receptors (19, 20). This has been recently reviewed 
in this journal (21) and elsewhere (22).  In the mouse, how- 
ever, it has only recently been possible to produce NK cell 
clones (23)  and the available  clones demonstrate an MHC 
class I-independent specificity that is not readily apparent in 
hybrid resistance.  Nevertheless, it has become clear that mu- 
rine NK cells are heterogeneous with respect to expression 
of certain cell surface molecules; several are involved in MHC 
class I-associated specificity. 
With particular relevance to hybrid resistance,  the Dallas 
group produced an mAb, SWSE6, that recognizes a disulfide- 
linked dimer, composed of 54-kD subunits, on a subpopula- 
tion of NK cells (24).  Although 5E6 § and 5E6-  NK cells 
appeared to have similar lytic capacity in vitro, injection of 
mAb SW5E6  into  F1  hybrid mice abrogated rejection of 
H-2  d but not H-2  b BMC.  This study was among the first 
to demonstrate specificity of murine NK cell subsets,  and 
it raised the possibility that the 5E6 molecule itself was in- 
volved in conferring this specificity. No direct evidence, how- 
ever, has been presented to show the direct involvement of 
the 5E6 molecule itself in NK cell recognition, and the struc- 
ture of the 5E6  antigen remained undefined. 
In this issue,  the Dallas group describes the cloning of a 
cDNA encoding the molecule recognized by mAb SWSE6 
(2).  Surprisingly, the 5E6 molecule (from C.B-17/scid/scid 
mice; C.B-17 is congenic to BALB/c) is identical in sequence 
to a member of the Ly-49 family of molecules, specifically 
Ly-49C, previously cloned from BALB/c mice (25).  (There 
is one codon difference but this may result from sequencing 
artifacts.) To evaluate the implications of Ly-49C in hybrid 
resistance,  it is useful to first review what is known about 
the Ly-49  family of molecules. 
The Ly-49 Family of  NK Cell Receptors.  The Ly-49A mol- 
ecule is a disulfide-linked homodimer that has the character- 
istics of a type II integral membrane protein with an external 
carboxyl terminus that is homologous to the C-type lectin 
superfamily (26). The gene encoding Ly-49A is clustered with 
a family of highly related genes on distal mouse chromosome 
6. Based on cDNA cloning studies, at least eight members 
(Ly-49A through Ly-49H) are transcribed primarily in NK 
cells (27, 28). Some of the transcripts produce molecules with 
varying degrees of in-frame deletions consistent with alter- 
native splicing.  The Ly-49 gene family is genetically linked 
to another cluster of genes encoding the NKR-P1 family of 
molecules (26). Though distinct by nucleotide sequence and 
genetic linkage analysis, the NKR-P1 genes encode molecules 
that share structural features with the Ly-49 family (disulfide- 
linked homodimers, type II integral membrane orientation, 
C-type lectin homology) and selective expression and func- 
tional activity on NK cells. Hence, this genomic region has 
been termed the NK gene complex. 
A current model for NK cell specificity involves activation 
receptors and MHC class I-specific inhibitory receptors (29). 
NKR-P1 molecules activate NK cells by apparently interacting 
with carbohydrate residues on targets (30), whereas Ly-49A 
globally inhibits NK cell cytolytic activity when targets ex- 
press  certain  murine MHC  class  I  molecules,  specifically 
H-2D a or H-2D k (31). Transfection and expression of H-2D d 
on an otherwise susceptible target inhibited natural killing 
by Ly-49A + IL-2-activated  NK cells. Moreover,  these targets 
could not be killed even when Ly-49A + effector cells were 
stimulated through activation pathways that are not physi- 
cally associated  on the cell surface and that trigger distinct 
proximal signaling events. Thus, this global inhibition of NK 
activity is consistent with the hypothesis that Ly-49A delivers 
an inhibitory signal upon engagement. 
Recent  evidence supports  a  direct  physical  interaction 
between  Ly-49A  and  H-2D d.  Experiments  demonstrated 
binding only between transfected cells expressing high levels 
of Ly-49A by DNA amplification and H-2D d, respectively 
(32). Ly-49 + tumor cell lines also bound to immunopurified 
D d molecules (33).  Binding was blocked by mAbs specific 
for Ly-49A or the otl/oL2 domains of D a. Similar interpre- 
tations are possible  from in vivo studies of Ly-49A expres- 
sion in MHC congenic, recombinant congenic, and trans- 
genic mice on the C57BL/6 or B10 background (34). Ly-49A 
expression  was  markedly diminished,  in  mice expressing 
H-2D a or D k. It was normally expressed in mice transgenic 
for soluble H-2D a, indicating that membrane-bound MHC 
class I was required for this effect. Studies with BM chimeric 
mice strongly suggested that downregulation resulted from 
extracellular engagement of Ly-49A with host MHC class 
I molecules (35).  This did not appear to be a result of nega- 
tive selection (clonal deletion), however, because Ly-49A could 
be detected at very low levels on highly purified NK cells 
(34). Thus, there is in vitro and in vivo evidence for physical 
interaction between Ly-49A and its MHC class I ligands, con- 
sistent with the role of Ly-49A as an MHC class I-specific 
receptor. 
These findings are not confined to Lyo49A. In this issue, 
Mason et al. (3) corroborate major aspects of the Ly-49A-H- 
2D  a paradigm with their studies on the LGL-1 molecule, an- 
other disulfide-linked homodimer expressed on an NK cell 
subset.  They isolated  a  cDNA  encoding LGL-1 in  C.B- 
17/scid/scid mice; the deduced polypeptide is 98% identical 
to Ly-49G2 from C57BL/6 mice (27).  Inasmuch as there is 
generally <90%  amino acid identity between Ly-49 family 
members in a single inbred strain (27),  the LGL-1 and Ly- 
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and C57BL/6 mice, respectively. This is also consistent with 
the distinct grouping of BALB/c and C57BL/6 strains, based 
on RFLP variants (36). Functional experiments indicated that 
LGL-1 expression could be correlated with target cell specificity; 
H-2 d targets were not killed by LGL-1 + NK cells (3). More- 
over, mAbs with apparent specificity for private determinants 
on H-2D d or L d mAb each abrogated this resistance,  sug- 
gesting that LGbl directly interacts with either MHC class 
I  molecule.  If,  however,  LGL,1  is  acting  as  an  inhibitory 
receptor specific for either ligand, binding to only one ligand 
should continue to protect because both MHC molecules are 
expressed on the target. It is therefore inconsistent that ei- 
ther anti-MHC class I mAb could restore killing to the level 
seen with anti-LGbl, raising the possibility that simultaneous 
binding to both MHC class I molecules is required for inhi- 
bition by LGbl. Further analyses with cell or physical binding 
experiments are necessary. Nevertheless, Ly-49 family members 
appear to be inhibitory MHC class I-specific NK cell receptors 
that significantly influence NK cell specificity. 
Ly-49C:  Implications for  Understanding Hybrid Resis- 
tance.  The finding that Ly-49C can be correlated with NK 
cell specificity in hybrid resistance is therefore a significant 
advance because it is a major clue to understanding the com- 
plexities in hybrid resistance.  Although it is formally pos- 
sible that Ly-49C is coexpressed with another molecule that 
is instead involved in determining specificity, it seems most 
plausible to hypothesize that Ly-49C itself is directly respon- 
sible by its ability to engage specific ligands, presumably MHC 
class I molecules. Two obvious functional consequences could 
occur after Ly-49C contacts its putative ligands. To result in 
graft acceptance, it could decrease NK cell cytolytic activity, 
analogous to Ly-49A, and/or change its cytokine production 
profile by producing cytokines that facilitate bone marrow 
growth or decrease the production of inhibitory cytokines. 
Absence of MHC class I molecules on BMC would then re- 
sult in increased NK cell cytotoxic activity or production of 
inhibitory cytokines and/or decreased production of stimula- 
tory cytokines. There seems to be less experimental support 
for the opposite functional consequence when Ly-49C con- 
tacts its MHC ligand, i.e., direct activation resulting in re- 
jection, but this remains formally possible particularly since 
it has been suggested that Ly-49G (LGL-1) can act as an acti- 
vation receptor under certain circumstances (3).  Moreover, 
in the rat, NK cells appear to be stimulated by (nonclassical) 
MHC class I determinants (37). The previous studies of Ly- 
49C, therefore, may be interpreted as having a role as either 
an activation or inhibitory receptor. 
To distinguish between these possibilities, it is critical to 
determine the ligand specificity of both alldic forms of Ly- 
49C in not only functional experiments, but  also binding 
experiments. Based on previous findings with Ly-49A, and 
consistent with previous data in hybrid resistance, the ligand 
for Ly-49C is likely to be a specific MHC class I molecule. 
Interestingly, Stoneman et al.  (2) describe preliminary data 
from functional experiments suggesting that Ly-49C interacts 
with H-2 a and H-2K b, imparting inability to kill targets ex- 
pressing these MHC class I molecules. These results are con- 
fusing in light of mapping data placing the genes for parental 
determinants near H-2D rather than H-2K subregion (1, 17). 
Moreover,  specificities of Ly-49C for both H-2 d and H-2  b 
haplotype molecules were not predictable from the in vivo 
experiments with mAb SW5E6 (24). To date, cell binding 
experiments corroborated the interaction of Ly-49C (BALB/c 
allele)  with cells from H-2 b and H-2 a haplotypes, but also 
indicated binding to cells from H-2 k and H-2* haplotypes 
(28). The specific MHC class I molecules involved have not 
been identified and the specificity for a C57BL/6 form of 
Ly-49C has not been determined. It is also unclear whether 
mAb SW5E6 binds both allelic forms and inhibits recogni- 
tion of MHC class I to an equal extent. Stoneman et al. (2) 
also refer to preliminary data implying differential cytokine 
production by different  Ly-49C  subsets in the  context of 
different MHC class I molecules. Yet, human NK cell clones 
appear to directly kill BMC rather  than to regulate their 
growth by cytokine production (37). Analysis of this possi- 
bility will also be aided by a more precise definition of the 
ligand specificity of Ly-49C alleles. 
Definition of lib-1 Determinants.  Precise identification of 
the putative MHC  class  I ligand for Ly-49C will make it 
feasible to begin addressing previous discrepancies in defining 
parental determinants in hybrid resistance. It is noteworthy 
that Ly-49A appears to interact with the c~1/c~2 domains of 
H-2D d, based on functional, binding, and in vivo expression 
analyses (31-34).  Ly-49A is thus reminiscent of the MHC 
class I-restricted TCR rather than the CD8 molecule that 
binds to the or3 domain of MHC class I molecules, consis- 
tent with the mutational analysis  of protective HLA mole- 
cules (13). The apparent involvement of the peptide binding 
domains in interaction with Ly-49A predicts that other Ly-49 
members also interact with similar MHC class  I domains. 
In the context of hybrid resistance, this could mean that bound 
peptides may play a role in determining the parental deter- 
minants and could be encoded by genes influencing Hh-1 
determinants. Recent studies, however, indicate only a general 
role for peptides in inducing the correct assembly, expres- 
sion, and conformation of MHC class  I molecules because 
all  tested  peptides  for  H-2D d could  confer  the  resistant 
phenotype (39). More extensive analysis with a broader panel 
of peptides may reveal other interpretations, but the current 
data suggest that Ly-49A molecules do not bind peptides 
directly, seemingly arguing against the possibility that Hh-1 
determinants result from specific MHC class I-bound peptides. 
Another implication that would arise from a definition of 
the MHC class I ligand for Ly-49C is related to the observa- 
tion that Ly-49 family members resemble Ca2+-dependent 
lectins (27). Moreover, Ly-49A has an apparent carbohydrate 
specificity (40). The specificity of Ly-49C, therefore, could 
involve glycosidic residues, perhaps on specific MHC  class 
I or on bound peptides. Such modifications could be regu- 
lated by genes linked to Hh-1. Alternatively, relevant epitopes 
on MHC class I molecules may be regulated in other ways 
as previously suggested (1). 
The involvement of the Ly-49 family in hybrid resistance 
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be MHC class  I molecules,  as defined by the specificity of 
promiscuous NK cell receptors. Ly-49A binds H-2D  d and D k 
in functional, binding, and in vivo expression studies (31-34), 
yet  H-2D a and  D k do  not  share  general  features  such  as 
structural or peptide motif, and they are distinct in sequence 
and serologic analysis.  On the other hand, they are both en- 
coded in the H-2D subregion, the genetic area linked to Hh-1, 
and may share as yet undefined epitopes involved in Ly-49A 
binding.  Similarly,  Ly-49G2 appears to be specific for H-2D  a 
and L d (3), unrelated except for derivation from H-2D sub- 
region (and in this case,  the H-2 a allele).  This promiscuity 
is also compatible with  the overlapping  specificities  of the 
Hh-1 groups (1). Classification of MHC class I determinants 
with regard to the specificity of NK cell receptors,  such as 
the Ly-49 family members, may therefore be revealing in un- 
derstanding  Hh-1 specificities,  as determined by in vivo hy- 
brid resistance  assays. 
Expressed  Functional Repertoire  of Ly-49 Molecules on NK 
Cells.  Available data strongly indicate that an individual NK 
cell may simultaneously express more than one Ly-49 family 
member. Compounding the difficulty of this analysis,  these 
molecules may have overlapping specificities.  For example, 
both Ly-49A and Ly-49G2 (LGL-1) appear to have specificity 
for H-2D d, and also D k and L d, respectively (2, 31-34).  In 
addition, multiple allelic forms for each Ly-49 family member 
are predicted from analysis of RFLP variants (36). It remains 
unclear whether each allelic  form has the same specificity. 
These issues are highly relevant to discussion of hybrid resis- 
tance because the F1 hybrid is heterozygous with respect to 
MHC and to allelic  forms of Ly-49 family members.  This 
raises  the additional prospect that  F1 hybrid NK cells may 
express heterodimers between allelic forms of individual Ly-49 
family members (normally homodimers on cells transfected 
with single cDNAs) and/or between family members, altering 
specificity for their ligands. Yet,  apparently only one aUelic 
form of Ly-49C is expressed in F1 hybrids, presumably be- 
cause of allelic exclusion (2). This important observation in- 
dicates that  not all pair combinations of Ly-49 alleles may 
be expressed, limiting the expressed diversity of these receptors. 
Recent data also suggest that the function (41) and expres- 
sion (34) of Ly-49A molecules may be influenced by host MHC 
class I molecules.  Thus,  further  dissection of hybrid resis- 
tance will require detailed understanding  of the expression 
and function of Ly-49 molecules on F1 hybrid NK cells in 
the context  of different host MHC class  I molecules. 
Finally,  the Ly-49C molecule is expressed only on a subset 
of NK cells and only this subset has the apparent specificity 
for H-2  a but not H-2 b BMC (24).  Why are Ly-49C-  NK 
cells not involved in mediating hybrid resistance in this strain 
combination? In addition to the considerations  above involving 
other Ly-49 family members with overlapping specificity with 
Ly-49C, perhaps other recognition mechanisms are involved, 
similar to the apparent Ly-49-independent specificity of re- 
cently described mouse NK cell clones (23). Further analysis 
of hybrid resistance therefore promises to enhance our un- 
derstanding of, not only MHC class I-associated specificity 
and the Ly-49 family, but of NK cell specificity in general. 
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